title: PHARMAC responds to Richard Milne on discounting health benefits and costs.
authors.forename: Scott
authors.initials: S
authors.lastname: Metcalfe
authors.forename: Matthew
authors.initials: M
authors.lastname: Brougham
authors.forename: Peter
authors.initials: P
authors.lastname: Moodie
authors.forename: Rachel
authors.initials: R
authors.lastname: Grocott
mesh_terms: D003362:Cost-Benefit Analysis; D004345:Drug Industry / Q000191:economics*; D017048:Health Care Costs / Q000639:trends*; D006801:Humans; D009313:National Health Programs / Q000191:economics* / Q000639:trends*; D009520:New Zealand